Study details
Enrolling now
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
University of Alabama at Birmingham
NCT IDNCT05437588ClinicalTrials.gov data as of Apr 2026
Target enrollment
240
Study length
about 4.7 years
Ages
10–24
Locations
2 sites in AL
What this study is about
This trial is testing if certain molecules, called microRNAs, found in blood can help predict how well people respond to treatment for depression and suicide. The goal is to find better ways to diagnose and treat these conditions.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Genetic testing
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Psychiatry / Mental Health